Open Access634 Transitioning From Vedolizumab IV to Vedolizumab SC in Patients With Ulcerative Colitis: Results From the VISIBLE Program
Author(s) -
Douglas C. Wolf,
Silvio Danese,
Barbara Matthews,
Stephen L. Jones,
Jingjing Chen,
Krisztina Kisfalvi,
William J. Sandborn
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592072.55730.89
Subject(s) - vedolizumab , medicine , placebo , ulcerative colitis , surgery , disease , pathology , alternative medicine